Plain-English translation of NCT07884669 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
GASTROTRACK is a research study looking for early warning signs of stomach cancer in body fluids and blood. Researchers will collect saliva, stomach fluid, and blood samples from people undergoing routine stomach screening procedures, then analyze these samples for special markers that might show cancer developing. The goal is to find better ways to catch stomach cancer before it becomes advanced.
Stomach cancer is often detected too late, when it's already spread. This study aims to discover biological markers—like patterns in saliva, stomach fluid, and blood—that could help doctors identify stomach cancer much earlier, when treatment is most effective.
You likely qualify if…
You likely don't qualify if…
If you join, you'll provide saliva and stomach fluid samples during your scheduled screening endoscopy. If cancer is found, you'll continue in the study with follow-up blood draws and monitoring at regular appointments during your treatment. The study will analyze your samples for biological markers that might help doctors detect stomach cancer earlier in future patients.
AI-generated summary from trial data · Nov 17, 2026 · Not medical advice
France